West Pharmaceutical Services reported $112.9M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Align Technology USD 410.55M 52.12M Sep/2026
Baxter International USD 730M 5M Sep/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Dentsply International USD 363M 1000K Sep/2026
Haemonetics USD 118.36M 580K Sep/2026
ICU Medical USD 154.41M 2.48M Sep/2026
Insulet USD 350.7M 5.9M Sep/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Neogen USD 100.8M 1000K Jun/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 182.7M 7M Sep/2026
Repligen USD 83.59M 6.97M Sep/2026
Rockwell Medical USD 4.04M 330K Jun/2024
Solventum Corp USD 813M 114M Sep/2026
STAAR Surgical USD 43.22M 1.92M Sep/2026
Terumo JPY 109.58B 120M Sep/2026
Utah Medical Products USD 2.56M 48K Mar/2026
West Pharmaceutical Services USD 112.9M 4.7M Sep/2026